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by Anita Boman.Amphibians are ancient creatures that have evolved effective
mechanisms to cope with a variety of microbes that they encounter
in those ecological niches where they often live, such as ponds,
soil, or mud. One of their ﬁrst defense systems to challenge
microbial infections includes gene-encoded antimicrobial peptides
(AMPs) that are synthesized and stored in dermal glands,
adrenergically innervated, and secreted into the skin mucus upon
alarm or injury. Noteworthy, AMPs are the main components of
innate immunity – a weapon that we all are “born with” – to
rapidly face harmful microorganisms, in both vertebrates and
invertebrates species.
Most AMPs are believed to kill pathogens by disrupting their
membranes and therefore they are considered as promising
templates for the development of new anti-infective therapeutics.
The production of novel antimicrobial agents is strongly demanded
because of the worldwide rapid increase of microbes with multi-
resistance phenotypes to the currently available drugs. In addition, it
is well-known that antibiotic therapy against Gram-negative bacteria
is frequently associated with the release of their outer membrane
components (endotoxin or lipopolysaccharide, LPS). LPS is a potent
stimulator of immune cells, inducing them to secrete several
cytokines, whose unbalanced production can eventually result in
septic shock syndrome, in humans and animals, with multi-organ
failure and ultimately death. Noteworthy, some AMPs from frog skin
can both kill microbes and detoxify LPS, which are two extremely
important properties for the development of new peptide-based
antibiotics.
Since 1987, when Michael Zasloff isolated magainins from skin
secretions of the African toad Xenopus laevis, numerous additional
AMPs have been identiﬁed in different anuran species and studied in
details. As a result, the frog skin is now known as one of the richest
sources for natural AMPs. They count hundreds of members, ranging
from 10 to 46 amino acids, and represent effector molecules not only
to protect the host from noxious invaders, but also to control/
modulate the animal's natural ﬂora.
Due to the rapid progress and expansion of this research area, it
would be impossible to condense here all the information on
amphibian AMPs. Therefore, this special issue attempts to provide
the reader with the discovery, structure-function relationships, and
mode(s) of action of the most studied AMPs from Anurans, their
derivatives or peptidomimetics on bacteria, fungi, protozoan parasites,
mammalian cells, and model membranes.
An introductory overview on the evolution and diversity of
distinct families of amphibian AMPs (e.g., dermaseptins, plasticins,
bombinins, buforins, brevinins, ranacyclins, ranatuerins, tempor-
ins) and derivatives, along with their structural features, biological
activities, and exploitation as new therapeutics, is followed by a0005-2736/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2009.05.016description of their ability to inhibit those pathogens responsible
for the continuous loss of amphibian populations on a global
scale.
Next, the issue focuses on the biophysical characterization and
the mode of action of the majority of the aforementioned peptides,
as well as of aureins, caerins, maculatins, esculentins, magainins,
PGLa, and pexiganan, upon their interaction with model membranes,
and their potential applications. The physico-chemical parameters
that control their cell selectivity are also discussed. Finally, the issue
ends by highlighting the mysteries that still remain to be discovered
on the antimicrobial defense mechanism that protects immature
tadpoles or developing frog embryos, where AMPs are not present.
Besides a few exceptions, frog skin AMPs are cationic, relatively
hydrophobic, and have the propensity to form amphipathic α-helical
structures in a membrane-mimetic environment. Although the
membrane of the pathogen has been shown as one of the targets of
most AMPs, the details of the molecular mechanism underlying their
antimicrobial activity are not yet fully understood.
To address this question, multidisciplinary approaches were
used aiming at unraveling the peptides' structure, conformation/
orientation within membranes, and the mechanisms by which they
(i) select and kill different microbes, including Gram-positive
bacteria, Gram-negative bacteria, fungi, and parasites; (ii) neutra-
lize the toxic effects of LPS; and (iii) synergize one with each other
in antimicrobial/anti-endotoxin activities.
Biological, spectroscopic, thermodynamic, and computational
methodologies have been employed to face these topics.
I hope that this special issuewill increase the interest in amphibian
AMPs and will give the reader a coherent picture of the emerging and
essential aspects of this vast class of peptides, also improving the
awareness on their in vivo role in vertebrates.
I wish to express my best thanks to all the authors and the reviewers
for their excellent contributions. A special gratitude goes to the Executive
Editors of BBA-Biomembranes and to the staff at Elsevier/BBA for their
assistance.Finally, I would like to dedicate this special
issue on Amphibian Antimicrobial Peptides to
Professor Emeritus Hans G. Boman, who
passed away on December 3, 2008, and with
whom I was personally lucky to work with at
Karolinska Institute in Stockholm. His original
scientiﬁc ideas and charismatic personality,
which led him assembling exciting and
creative research environments, deeply
attracted me to the ﬁeld of peptide-mediated
innate-immunity.
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